These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 17514622)
1. TGF-beta1 in chronic allograft nephropathy following renal transplantation. Harris S; Coupes BM; Roberts SA; Roberts IS; Short CD; Brenchley PE J Nephrol; 2007; 20(2):177-85. PubMed ID: 17514622 [TBL] [Abstract][Full Text] [Related]
2. [Role of transforming growth factor beta-1 gene polymorphisms in the development of chronic allograft nephropathy in renal transplant recipients]. Iñigo P; Lario S; Campistol JM; Bescós M; Campos B; Oppenheimer F Nefrologia; 2003; 23(4):312-20. PubMed ID: 14558330 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta 1 in renal allograft recipients. Coupes BM; Newstead CG; Short CD; Brenchley PE Transplantation; 1994 Jun; 57(12):1727-31. PubMed ID: 8016876 [TBL] [Abstract][Full Text] [Related]
4. TNF-alpha and TGF-beta1 gene polymorphisms and renal allograft rejection in Koreans. Park JY; Park MH; Park H; Ha J; Kim SJ; Ahn C Tissue Antigens; 2004 Dec; 64(6):660-6. PubMed ID: 15546338 [TBL] [Abstract][Full Text] [Related]
5. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with chronic allograft nephropathy and graft survival in Korean renal transplant recipients. Cho JH; Huh S; Kwon TG; Choi JY; Hur IK; Lee EY; Park SH; Kim YL; Kim CD Transplant Proc; 2008 Sep; 40(7):2355-60. PubMed ID: 18790234 [TBL] [Abstract][Full Text] [Related]
6. [Association between transforming growth factor beta-1 gene polymorphism and chronic allograft nephropathy]. Li CJ; Yu LX; Xu J; Fu SJ; Deng WF; DU CF; Wang YB Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):535-7. PubMed ID: 17545053 [TBL] [Abstract][Full Text] [Related]
7. [Expressions of transforming growth factor-beta1 and collagen IV in renal tissues of patients with chronic allograft nephropathy]. Han CX; Yu LX; Xu J; Xie QX; Wang YB; Deng WF; Liu XY; Zeng JH Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):567-9. PubMed ID: 15897139 [TBL] [Abstract][Full Text] [Related]
8. Molecular and clinical response to angiotensin II receptor antagonist in kidney transplant patients with chronic allograft nephropathy. Mas VR; Alvarellos T; Maluf DG; Ferreira-Gonzalez A; Oliveros L; Maldonado RA; de Boccardo G Transpl Int; 2004 Oct; 17(9):540-4. PubMed ID: 15349718 [TBL] [Abstract][Full Text] [Related]
9. The effect of different immunosuppressive regimens on TGF-beta1 expression in kidney transplant patients. Matl I; Viklický O; Voska L; Lodererová A; Vítko S Transpl Int; 2005 Jun; 18(6):668-71. PubMed ID: 15910291 [TBL] [Abstract][Full Text] [Related]
11. The natural history of chronic allograft nephropathy. Nankivell BJ; Borrows RJ; Fung CL; O'Connell PJ; Allen RD; Chapman JR N Engl J Med; 2003 Dec; 349(24):2326-33. PubMed ID: 14668458 [TBL] [Abstract][Full Text] [Related]
12. [Effect of cytomegalovirus infection on long-term renal allograft function]. Tang B; Lv PY; Xu FY; Zheng KL; Liu D Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1588-91. PubMed ID: 19726300 [TBL] [Abstract][Full Text] [Related]
13. Expression of transforming growth factor-beta1 and hypoxia-inducible factor-1alpha in renal transplantation. Lee S; Kim DJ; Park MG; Park SK; Kim JS; Hyun SJ; Oh JE; Nam ES; Joo SH Transplant Proc; 2008 Sep; 40(7):2147-8. PubMed ID: 18790176 [TBL] [Abstract][Full Text] [Related]
14. [Association between TGF-Beta1 in allograft and chronic allograft nephropathy]. Wang PX; Fan MQ; Gong GZ; Xu HY; Huang CB; Zhang GT Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):112-4, 122. PubMed ID: 16468656 [TBL] [Abstract][Full Text] [Related]
15. [Influence of transforming growth factor beta1 on long-term renal allograft function]. Wang PX; Fan MQ; Huang CB; Zhnag GF Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1352-5. PubMed ID: 16982454 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker. Zhu S; Liu Y; Wang L; Meng QH Nephrol Dial Transplant; 2008 Sep; 23(9):2841-6. PubMed ID: 18390891 [TBL] [Abstract][Full Text] [Related]
17. [TGF-beta1 in allograft and long-term renal function]. Wang PX; Huang XY; Wang AJ; Huang CB; Fan MQ; Zhang YP Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):700-3. PubMed ID: 16114562 [TBL] [Abstract][Full Text] [Related]
18. Prediction of chronic renal allograft dysfunction from evaluations of TGFBeta1 and the renin-angiotensin system. Yamada K; Hatakeyama E; Arita S; Sakamoto K; Kashiwabara H; Hamaguchi K Clin Exp Nephrol; 2003 Sep; 7(3):238-42. PubMed ID: 14586721 [TBL] [Abstract][Full Text] [Related]
19. beta6 integrin is up-regulated in chronic renal allograft dysfunction. Sawada T; Abe M; Kai K; Kubota K; Fuchinoue S; Teraoka S Clin Transplant; 2004 Oct; 18(5):525-8. PubMed ID: 15344954 [TBL] [Abstract][Full Text] [Related]
20. Atorvastatin treatment in the short term: does it induce renoprotection or vasculoprotection in renal transplantation? Navarro-Muñoz M; Bonet J; Bayés B; Lauzurica R; Blanco S; Romero R Transplant Proc; 2007 Sep; 39(7):2259-63. PubMed ID: 17889157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]